These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16474399)

  • 41. Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy.
    Tietze JK; Wilkins DE; Sckisel GD; Bouchlaka MN; Alderson KL; Weiss JM; Ames E; Bruhn KW; Craft N; Wiltrout RH; Longo DL; Lanier LL; Blazar BR; Redelman D; Murphy WJ
    Blood; 2012 Mar; 119(13):3073-83. PubMed ID: 22251483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rescue of Tolerant CD8+ T Cells during Cancer Immunotherapy with IL2:Antibody Complexes.
    Klevorn LE; Berrien-Elliott MM; Yuan J; Kuehm LM; Felock GD; Crowe SA; Teague RM
    Cancer Immunol Res; 2016 Dec; 4(12):1016-1026. PubMed ID: 27803062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming.
    Le Bon A; Durand V; Kamphuis E; Thompson C; Bulfone-Paus S; Rossmann C; Kalinke U; Tough DF
    J Immunol; 2006 Apr; 176(8):4682-9. PubMed ID: 16585561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells.
    Butler MO; Friedlander P; Milstein MI; Mooney MM; Metzler G; Murray AP; Tanaka M; Berezovskaya A; Imataki O; Drury L; Brennan L; Flavin M; Neuberg D; Stevenson K; Lawrence D; Hodi FS; Velazquez EF; Jaklitsch MT; Russell SE; Mihm M; Nadler LM; Hirano N
    Sci Transl Med; 2011 Apr; 3(80):80ra34. PubMed ID: 21525398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells.
    Schluns KS; Klonowski KD; Lefrançois L
    Blood; 2004 Feb; 103(3):988-94. PubMed ID: 14512307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined anti-CD40 conditioning and well-timed immunization prolongs CD8+ T cell accumulation and control of established brain tumors.
    Ryan CM; Staveley-O'Carroll K; Schell TD
    J Immunother; 2008; 31(9):906-20. PubMed ID: 18832997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The future of interleukin-2: enhancing therapeutic anticancer vaccines.
    Overwijk WW; Theoret MR; Restifo NP
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1(Suppl 1):S76-80. PubMed ID: 10685664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation.
    Nada MH; Wang H; Workalemahu G; Tanaka Y; Morita CT
    J Immunother Cancer; 2017; 5():9. PubMed ID: 28239463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance.
    Papatriantafyllou M; Moldenhauer G; Ludwig J; Tafuri A; Garbi N; Hollmann G; Küblbeck G; Klevenz A; Schmitt S; Pougialis G; Niehrs C; Gröne HJ; Hämmerling GJ; Arnold B; Oelert T
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1631-6. PubMed ID: 22307622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyper-IL-15 suppresses metastatic and autochthonous liver cancer by promoting tumour-specific CD8+ T cell responses.
    Cheng L; Du X; Wang Z; Ju J; Jia M; Huang Q; Xing Q; Xu M; Tan Y; Liu M; Du P; Su L; Wang S
    J Hepatol; 2014 Dec; 61(6):1297-303. PubMed ID: 25016226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune tolerance after delivery of dying cells to dendritic cells in situ.
    Liu K; Iyoda T; Saternus M; Kimura Y; Inaba K; Steinman RM
    J Exp Med; 2002 Oct; 196(8):1091-7. PubMed ID: 12391020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors.
    Xin G; Schauder DM; Jing W; Jiang A; Joshi NS; Johnson B; Cui W
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):740-745. PubMed ID: 28069963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor.
    Teague RM; Greenberg PD; Fowler C; Huang MZ; Tan X; Morimoto J; Dossett ML; Huseby ES; Ohlén C
    Immunity; 2008 May; 28(5):662-74. PubMed ID: 18424189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.
    Stromnes IM; Blattman JN; Tan X; Jeevanjee S; Gu H; Greenberg PD
    J Clin Invest; 2010 Oct; 120(10):3722-34. PubMed ID: 20890046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modifications of CD8+ T cell function during in vivo memory or tolerance induction.
    Tanchot C; Guillaume S; Delon J; Bourgeois C; Franzke A; Sarukhan A; Trautmann A; Rocha B
    Immunity; 1998 May; 8(5):581-90. PubMed ID: 9620679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15.
    Yao J; Ly D; Dervovic D; Fang L; Lee JB; Kang H; Wang YH; Pham NA; Pan H; Tsao MS; Zhang L
    J Immunother Cancer; 2019 Jan; 7(1):17. PubMed ID: 30670085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eradication of established tumors by CD8+ T cell adoptive immunotherapy.
    Hanson HL; Donermeyer DL; Ikeda H; White JM; Shankaran V; Old LJ; Shiku H; Schreiber RD; Allen PM
    Immunity; 2000 Aug; 13(2):265-76. PubMed ID: 10981969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer.
    Sierra RA; Thevenot P; Raber PL; Cui Y; Parsons C; Ochoa AC; Trillo-Tinoco J; Del Valle L; Rodriguez PC
    Cancer Immunol Res; 2014 Aug; 2(8):800-11. PubMed ID: 24830414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy.
    Verdeil G; Marquardt K; Surh CD; Sherman LA
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16683-8. PubMed ID: 18936481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generating stem-like memory T cells with antioxidants for adoptive cell transfer immunotherapy of cancer.
    Pilipow K; Scamardella E; Lugli E
    Methods Enzymol; 2020; 631():137-158. PubMed ID: 31948545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.